Search

everythinglearnresearchcommunity

for

Search:↓

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

A healthy woman got a chest abscess from a fungal infection after gallbladder surgery, which was treated but caused temporary hair loss due to the antifungal medication.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

A woman got a serious eye infection after a hair loss treatment due to improper procedure.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Injecting a person's own fat stem cells into their skin can make it look younger and improve double eyelids for over a year.

Using focused ultrasound on the brain can help epilepsy medicine work better in rats.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

No single treatment is clearly effective for central serous chorioretinopathy.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.